Aurinia
Aurinia Pharmaceuticals Inc., commonly referred to as Aurinia, is a biopharmaceutical company headquartered in Canada. Founded in 2013, Aurinia focuses on developing innovative therapies for autoimmune diseases, with a particular emphasis on lupus nephritis. The company has made significant strides in the industry, notably with the launch of its flagship product, LUPKYNIS™ (voclosporin), which offers a unique mechanism of action that enhances treatment options for patients. With a strong presence in North America and expanding operations in Europe, Aurinia has established itself as a leader in the autoimmune disease sector. The company’s commitment to research and development, coupled with its strategic partnerships, has positioned it favourably in the market, earning recognition for its contributions to patient care and treatment advancements.
DitchCarbon Score
How does Aurinia's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aurinia's score of 20 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Aurinia's reported carbon emissions
In 2023, Aurinia reported total carbon emissions of approximately 218,430 kg CO2e, a notable increase from 198,740 kg CO2e in 2022. The emissions for 2022 were solely from Scope 2, indicating that all reported emissions were related to indirect energy consumption. In contrast, the 2023 data does not specify the breakdown of emissions by scope, but it reflects a total increase in emissions. Aurinia has not disclosed any specific reduction targets or initiatives as part of their climate commitments. This lack of defined goals suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As a company headquartered in Canada, Aurinia operates within an industry context that increasingly prioritises sustainability and carbon footprint reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | - |
| Scope 2 | 198,740 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aurinia is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
